Financial Statements/ESG Information - [Environmental, Social and Governance Information/Report]

Viva Biotech Holdings operates as a drug discovery platform. The Company provides target protein expression, structure researching, hit screening, drug candidate determination, and other services. Viva Biotech Holdings serves customers worldwide.

2024 Environmental, Social And Governance Report

Form Of Proxy For Use At Annual General Meeting

Announcements and Notices - [Notice of AGM / Closure of Books or Change of Book Closure Period]

Notice Of Annual General Meeting

Circulars - [Re-election or Appointment of Director subject to Shareholders' Approval / General Mandate / Explanatory Statement for Repurchase of Shares]

Proposed Re-Election Of Retiring Directors Proposed Re-Appointment Of Auditor Proposals For Granting Of General Mandates To Issue Shares And Repurchase Shares And Notice Of Annual General Meeting

Financial Statements/ESG Information - [Annual Report]

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Viva Biotech Holdings (1873 HK)

2024 Environmental, Social And Governance Report

Form Of Proxy For Use At Annual General Meeting

Notice Of Annual General Meeting

Proposed Re-Election Of Retiring Directors Proposed Re-Appointment Of Auditor Proposals For Granting Of General Mandates To Issue Shares And Repurchase Shares And Notice Of Annual General Meeting

2024 Annual Report

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)